EyePoint PharmaceuticalsDaniel Malowany2022-12-19T17:28:08+00:00 Project Description Follow-On OfferingCommon Stock .$115,000,000 Financial AdvisorNovember 2021 Related Project Details Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail